- Country: Estonia
- Summary: Buying Hormone Preparations with a Systemic Effect
- EET Ref No: 111639830
- Deadline: 22 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 900.00
- Notice Type: Tender
- Document Ref. No.: 759553-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase of hormone preparations with systemic effect for 24 months according to real need
argipressin infusion solution concentrate 40TU
desmopressin injection solution 15mcg
demoxytocin tablet 50TU
oxytocin injection/infusion solution i.m./ i.v. 5 IU
carbetocin injection solution 100mcg
octreotide injection/infusion solution - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBuying Hormone Preparations with a Systemic Effect - Estonia Tender
The JOINT-STOCK COMPANY LAANE-TALLINN CENTRAL HOSPITAL, a Government sector organization in Estonia, has announced a new tender for Buying Hormone Preparations with a Systemic Effect. This tender is published on EstoniaTenders under EET Ref No: 111639830 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-22.
The estimated tender value is EUR 900.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
